Literature DB >> 25684110

¹⁹F nuclear magnetic resonance screening of glucokinase activators.

O Assemat1, M Antoine2, J-M Fourquez3, M Wierzbicki3, Y Charton3, P Hennig3, F Perron-Sierra3, G Ferry2, J A Boutin4, M-A Delsuc5.   

Abstract

Human hexokinase enzyme IV (EC 2.7.1.1) catalyzes the phosphorylation of glucose and regulates the level of glucose. This enzyme exhibits strong positive cooperativity due to an allosteric transition between an inactive form and a closed active form. This form can be stabilized by activators and, thus, can increase its turnover by a kinetic memory effect characterized by a slow decay to the inactive state. The structural details of this kinetic allostery are known. Several synthetic activators have been reported. We present a preliminary nuclear magnetic resonance (NMR) screening of a chemical library in search of molecules with some affinity for glucokinase (GK). The library, composed of eight molecules with known activity as well as molecules that display no interaction, has been tested using the FAXS (fluorine chemical shift anisotropy and exchange for screening) method, based on monitoring the R2 relaxation of the (19)F spin. To ensure a valid interaction measurement, the enzyme was placed in the presence of glucose and magnesium. The binding signal of one known fluorinated ligand was measured by determining the displacement of the known ligand. This simple measure of the (19)F signal intensity after an 80-ms spin echo correlates nicely with the EC50, opening a route for NMR screening of GK activators.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  (19)F spin signal; Enzyme-activating assay; Glucokinase; Ligands; NMR

Mesh:

Substances:

Year:  2015        PMID: 25684110     DOI: 10.1016/j.ab.2015.02.006

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  1 in total

1.  Practical Considerations and Guidelines for Spectral Referencing for Fluorine NMR Ligand Screening.

Authors:  Yann Ayotte; Simon Woo; Steven R LaPlante
Journal:  ACS Omega       Date:  2022-04-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.